Innovatus Life Sciences Acquisition Corp.
This life sciences-focused blank check company, or SPAC, withdrew its IPO plans in an SEC filing dated July 20, 2022. This IPO was planned as a stock-only deal – no warrants.
|Address||777 Third Avenue, 25th Floor New York, New York 10017|
|Phone Number||(212) 698-4580|
|View Prospectus:||Innovatus Life Sciences Acquisition Corp.|
|Revenues||$0 mil (last 12 months)|
|Net Income||$0 mil (last 12 months)|
|Price range||$10.00 - $10.00|
|Est. $ Volume||$175.0 mil|
|Manager / Joint Managers||UBS Investment Bank|
|Expected To Trade:|
|Quiet Period Expiration Date:||Available only to Subscribers|
|Lock-Up Period Expiration Date:||Available only to Subscribers|
|SCOOP Rating||Available only to Subscribers|
|Rating Change||Available only to Subscribers|